Dragonfly Therapeutics Expands Clinical Leadership Team
Appointing Dr. Hesham Aboshady as Head of Safety & Pharmacovigilance and Rajesh Israni as Head of Regulatory Affairs.
Hesham Aboshady MD, MPH brings 10+ years of drug safety experience to and Rajesh Israni brings 20+ years of regulatory experience, to Dragonfly Therapeutics.
WALTHAM, Mass., March 30, 2022 /PRNewswire/ -- Dragonfly Therapeutics, Inc. ("Dragonfly" or the "Company"), today announced it has expanded its Clinical Leadership Team with the addition of Dr. Hesham Aboshady, an experienced clinician as Head of Drug Safety, and Rajesh Israni as Head of Regulatory.
"We are delighted that Hesham and Rajesh have joined Dragonfly," said Bill Haney, co-founder and CEO of Dragonfly Therapeutics. "Their impressive accomplishments and experience in drug development, with expertise in regulatory and drug safety strategy, will be invaluable in managing our deep pipeline and leading multiple novel drug candidates successfully into the clinic."
Hesham Aboshady, M.D., MPH is a pharmacovigilance leader with broad expertise in clinical development of immuno-oncology, oncology and immunology therapeutic agents. He has held pharmacovigilance and drug safety roles at Boehringer Ingelheim and Regeneron, and most recently, was Associate Vice President of Clinical Safety and Risk Management at Merck where he was part of the KEYTRUDA development team. Dr. Aboshady received an MD from Cairo University, a Master of Public Health from the University of Oklahoma and completed an Internal Medicine Residency at Brown University Warren Alpert School of Medicine. Before joining the pharmaceutical industry, Hesham was a practicing internist in Milford Massachusetts and an Assistant Professor of Medicine at the University of Massachusetts.
Rajesh Israni brings deep experience in leading regulatory strategy for early-stage and late-stage global registrational trials. Mr. Israni spent two decades at Bristol Myers Squibb and Sanofi in various roles of increasing responsibility, providing leadership for development and execution of global regulatory strategies, including global approvals of elotuzumab, nivolumab and nivolumab plus ipilimumab combinations in several indications. More recently, he led the the regulatory strategy team at Seagen Inc, responsible for developing and executing global registration strategies for both early and late-stage programs, including approvals for PADCEV®. Mr. Israni holds two Master's Degrees; one in Biotechnology and Genomics from Rutgers University, NJ, and one in Information Systems and Strategy from Stevens Institute of Technology, NJ.
About Dragonfly Dragonfly Therapeutics is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing therapies that use its novel technology to harness the body's innate immune system to bring breakthrough treatments to patients. Dragonfly has a deep pipeline of wholly-owned clinical and preclinical candidates discovered using its proprietary platform that are progressing toward the clinic, as well as productive collaborations with Bristol Myers Squibb, Merck and Abbvie across a broad range of disease areas. For more information visit us at www.Dragonflytx.com, or follow us on Linkedln and Twitter.
DRAGONFLY MEDIA CONTACT: Anne E. Deconinck | anne@dragonflytx.com
SOURCE Dragonfly Therapeutics, Inc.
Correctly identifying the gateway is an important first step when dealing with 192.168.0.1 login, and this website provides useful background for that purpose.
Energy efficiency is another consideration when selecting swimming pool enclosures. A suitable structure can help reduce heat loss by creating a barrier between the pool area and outdoor conditions. Depending on the enclosure design, it may also allow sunlight to warm the surrounding space naturally. Reduced heat loss can potentially lower the amount of energy required to maintain comfortable temperatures. Homeowners should https://www.coversinplay.com consider local weather, pool heating systems, enclosure materials, and ventilation when evaluating energy-saving possibilities for their property.
Bahut achhi information share ki gayi hai. hindi varnmala mein kitne swar hote hain ke basic letters samajhne mein bachchon ko zaroor help milegi.
Accounting software can make it easier to organize information that might otherwise become scattered across spreadsheets and paper documents. A QuickBooks software download can support a more centralized bookkeeping process for eligible users. Before transferring information, users should review existing records and remove unnecessary duplicates. Creating a backup before migration is also a sensible https://paygration.com precaution. Once the information is organized, users can establish consistent procedures for entering new transactions and reviewing financial records throughout the year.
SriWin appeared while I was browsing through different gaming-related topics. Rather than focusing only on the games, I would first look at how the account system works and what conditions apply. Privacy information, payment details, and individual game rules are all worth checking before using any platform.